Studies on Hepatitis B and D Viruses Co-Infection in Egyptian Hemodialysis Patients
DOI:
https://doi.org/10.21608/jntas.2023.208632.1056Keywords:
Hepatitis B (HBV), Hepatitis D (HDV), Medical Biotechnology, Renal dysfunctionAbstract
Hepatitis D virus (HDV) infection is exceedingly pathogenic, and it aggravates the natural viral hepatitis B (HBV) infection by progressing to cirrhosis. Therefore, we aimed to ascertain the incidence, prevalence, and features of hepatitis B and/or D virus co-infection in individuals with renal impairment. A total of 92 renal patients were enrolled in the study between October 2017 and November 2021. Liver and kidney functions were assessed, and HBsAg, IgM anti-HDV, and total HDV antibodies were detected to determine HBV/HDV coinfection.We found that HBV/HDV coinfection is more common in patients with renal failure than in renal insufficiency. Furthermore, 26.1% (24 of a total 92) of patients with (HBV) renal failure and 5.4% (5 of a total 92) of individuals with (HBV) renal insufficiency showed antibodies to (HDV). HBV/HDV coinfection resides in rural areas than in urban ones. Alanine transaminase (ALT) is in the normal range, while aspartate transaminase (AST), total and direct bilirubin (T Bil), (D Bil), creatinine, uric acid, and urea serum levels, and Prothrombin time (PT) were high, and albumin (ALB) was decreased.In addition, the death rate in renal patients infected with virus 19 out of a total of 29 (virus B infection), including 13 co-infections with the virus. It is concluded that among the examined (HBV) & (HDV) renal patients, renal impairment may significantly increase the prevalence and incidence of hepatitis infection due to the weakening of the immune system of patients. If coinfection is not treated, this will result in 100% death.
References
Abbasi, A. H., Riaz, A., Andaleeb, H., Qureshi, M. O., Yousuf, N., & Ahmed, K. (2022). Predictive factors in the incidence of liver cirrhosis in chronic hepatitis B mono-infection in comparison with HBV/HDV co-infection. Journal of Gastroenterology and Hepatology, 11(4), 3737.
Alexander, J., Stockdale, A. J., Benno, K., Marc, Y. R., Henrion, M. Y., Geretti, A. M., & colleagues. (2020). The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. Journal of Hepatology, 73, 523.
Almeida, P. H., Matielo, C. E., Curvelo, L. A., Rocco, R. A., Felga, G., Della Guardia, B., & Boteon, Y. L. (2021). Update on the management and treatment of viral hepatitis. World Journal of Gastroenterology, 27(23), 3249.
Bakhshipour, A., Mashhadi, M., Mohammadi, M., & Nezam, S. K. (2013). Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan. Acta Medica Iranica, 51(4), 260.
Bernieh, B. (2015). Viral hepatitis in hemodialysis: An update. Journal of Translational Internal Medicine, 3(3), 93.
Chang, L., Yan, Y., Ji, H., Sun, H., Jiang, X., Lu, Z., & Wang, L. (2022). Low seroprevalence of hepatitis delta virus co-infection in hepatitis B virus-infected blood donors in China: A multicenter study. Frontiers in Microbiology, 13, 992817.
Chen, H., Shen, D., Ji, D., Han, P., Zhang, W., & Ma, J. (2018). Prevalence and burden of hepatitis D virus infection in the global population: A systematic review and meta-analysis. Gut, 68, 512.
European Association for the Study of the Liver. (2017). EASL clinical practice guidelines on the management of hepatitis B virus infection. Journal of Hepatology, 67, 370.
Fabrizi, F., Messa, P., & Martin, P. (2008). Hepatitis B virus infection and the dialysis patient. Seminars in Dialysis, 21(5), 440.
Ishigami, J., & Matsushita, K. (2019). Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clinical and Experimental Nephrology, 23(4), 437.
Levin, A., Hemmelgarn, B., Culleton, B., et al. (2008). Guidelines for the management of chronic kidney disease. Canadian Medical Association Journal, 179(11), 1154.
Martin, Z., & Eberhard, R. (2022). Preparation of the dialysis patient for transplantation. Nephrology Dialysis Transplantation, 17(4), 552.
Mentha, N., Clément, S., Negro, F., & Alfaiate, D. (2019). A review on hepatitis D: From virology to new therapies. Journal of Advanced Research, 17, 3.
Moghaddam, S. M., Imani, A. A., Rizzetto, M., & Alavian, S. M. (2009). Viral hepatitis D among hemodialysis patients: A worldwide underestimated problem. Hepatitis Monthly, 9, 305.
Mousa, A. A., Awad, R., Fatahallah, D., Shageen, A., & Zein El Abedine, L. (2014). Prevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases (Master’s thesis). Al-Azhar University, Faculty of Science, Cairo.
Nelson, N. P., Easterbrook, P. J., & McMahon, B. J. (2017). Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clinical Liver Disease, 20(4), 607.
Noureddin, M., & Gish, R. (2014). Hepatitis delta: Epidemiology, diagnosis, and management 36 years after discovery. Current Gastroenterology Reports, 16(1), 365.
Hussein, N. (2018). Risk factors of hepatitis B virus infection among blood donors in Duhok City, Kurdistan Region, Iraq. Caspian Journal of Internal Medicine, 9(1), 22.
Polaris Observatory Collaborators. (2018). Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study. The Lancet Gastroenterology & Hepatology, 3, 383.
Ramia, S., El-Zaatari, M., Sharara, A. I., Ramlawi, F., & Farhat, B. (2007). Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon. Epidemiology and Infection, 135, 959.
Ringelhan, M., McKeating, J. A., & Protzer, U. (2017). Viral hepatitis and liver cancer. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1732), 20160274.
Roshandel, G., Semnani, S., Abdolahi, N., Besharat, S., Keshtkar, A. A., & Joshaqani, H. (2008). Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan Province, northeast Iran. Journal of Microbiology, Immunology and Infection, 41(3), 227.
Sheng, W. H., Hung, C. C., Kao, J. H., Chang, S. Y., Chen, M. Y., & Hsieh, S. M. (2007). Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study. Clinical Infectious Diseases, 44, 988.
Tyng-Yuan, J., Yu-Ju, W., Ming-Lun, Y., Shu-Fen, L., & Cheng-Ting, H. (2021). Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues. Journal of the Formosan Medical Association, 120(1), 303.
Wang-Huei, S., Chien-Ching, H., Jia-Horng, K., Sui-Yuan, C., Mao-Yuan, C., Szu-Min, H., Pei-Jer, C., & Shan-Chwen, C. (2007). Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study. Clinical Infectious Diseases, 44(7), 988.
Wedemeyer, H., & Negro, F. (2019). Devil hepatitis D: An orphan disease or largely underdiagnosed? Gut, 68, 381.
World Health Organization. (2015). World report on ageing and health. World Health Organization.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
